171
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis

, , &
Pages 177-194 | Published online: 23 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maria Ilenia Passalacqua, Graziella Rizzo, Mariacarmela Santarpia & Giuseppe Curigliano. (2022) ‘Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research’. Expert Opinion on Investigational Drugs 31:12, pages 1291-1310.
Read now

Articles from other publishers (3)

Carla E. Schulmeyer, Peter A. Fasching, Lothar Häberle, Julia Meyer, Michael Schneider, David Wachter, Matthias Ruebner, Patrik Pöschke, Matthias W. Beckmann, Arndt Hartmann, Ramona Erber & Paul Gass. (2023) Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis. Diagnostics 13:3, pages 372.
Crossref
Miguel Muñoz, Marisa Rosso & Rafael Coveñas. (2020) Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach. Mini-Reviews in Medicinal Chemistry 20:5, pages 408-417.
Crossref
Mercedes Herrera Juarez, Pablo Tolosa Ortega, Ana Sanchez de Torre & Eva Ciruelos Gil. (2020) Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features. Breast Care 15:3, pages 208-216.
Crossref